Coronavirus vaccine developed in China shows promise after early study in 100 people  Live ScienceView Full Coverage on Google News
A potential coronavirus vaccine developed in China appeared safe and able to generate an immune response after an early trial in more than 100 people.The vaccine appeared safe and able to generate an immune response.

Coronavirus vaccine tested in China shows promise after early study in 100 people | Live Science

The first COVID-19 vaccine to reach clinical trials in humans was determined to be both safe and generate an immune response against the virus -- a "milestone" in the battle to defeat the deadly bug, a new study found.The first COVID-19 vaccine to reach clinical trials in humans was determined to be both safe and generate an immune response against the virus — a “milestone” in the battle to defeat

Coronavirus vaccine gets positive results in first human trial

“The U.S. government is providing billions to the drug companies to develop a COVID-19 vaccine. Once that vaccine is approved by the FDA, it must be available to all for free. We've already paid for it. This is not a time for pharmaceutical industry profiteering.”

Bernie Sanders on Twitter: "The U.S. government is providing billions to the drug companies to develop a COVID-19 vaccine. Once that vaccine is approved by the FDA, it must be available to all for free. We've already paid for it. This is not a time for pharmaceutical industry profiteering."

“This is what our government is paying to develop a COVID19 vaccine: - $1.2 billion to AstraZeneca - $483 million to Moderna - $500 million to Johnson & Johnson - $30 million to Sanofi Once a vaccine is approved by the FDA, it must be available to all for free. No profiteering.”

Bernie Sanders on Twitter: "This is what our government is paying to develop a COVID19 vaccine: - $1.2 billion to AstraZeneca - $483 million to Moderna - $500 million to Johnson & Johnson - $30 million to Sanofi Once a vaccine is approved by the FDA, it must be available to all for free. No profiteering."

“Nobody has been more supportive of @UniofOxford #Coronavirus vaccine than I, but why are five year old children, who cannot possibly consent, being given an experimental vaccine, even in a second stage trial? Neither @BBCNews nor the University's website explains”

Louise Mensch on Twitter: "Nobody has been more supportive of @UniofOxford #Coronavirus vaccine than I, but why are five year old children, who cannot possibly consent, being given an experimental vaccine, even in a second stage trial? Neither @BBCNews nor the University's website explains"

“Part of what makes me proud to be an Ontarian is the people. Ontario has been the home to many scientific discoveries, there’s no reason we can’t find a vaccine for #COVID19 right here. We’re supporting promising proposals that are looking for long-term solutions. https://t.co/gHLtDN256i”

Doug Ford on Twitter: "Part of what makes me proud to be an Ontarian is the people. Ontario has been the home to many scientific discoveries, there’s no reason we can’t find a vaccine for #COVID19 right here. We’re supporting promising proposals that are looking for long-term solutions.… https://t.co/6zs6TaKwbQ"

Within two weeks of getting the vaccine, some developed so-called neutralizing antibodies, which can block SARS-CoV-2, the virus that causes COVID-19.Within two weeks of getting the vaccine, some developed so-called neutralizing antibodies, which can block SARS-CoV-2, the virus that causes COVID-19.

Coronavirus vaccine trial in China gets 'promising' early results

Using a series of prototype vaccines—ones used for medical research only and not intended for human use—researchers found that the interventions prevented rhesus macaques from becoming infected by the novel coronavirus. In a related experiment, macaques that tested positive for the virus were protected from re-infection when they encountered it a second time.Using a series of prototype vaccines—ones used for medical research only and not intended for human use—researchers found that the interventions prevented rhesus macaques from becoming infected by the novel coronavirus. In a related experiment, macaques that tested positive for the virus were protected from re-infection when they encountered it a second time.

Studies in monkeys show that coronavirus immunity holds up in vaccine treatments | Popular Science

The first COVID-19 vaccine to reach phase 1 clinical trial has been found to be safe, well-tolerated, and able to generate an immune response against SARS-CoV-2 in humans, according to new research published ...

First human trial of COVID-19 vaccine finds it is safe and induces rapid immune response

Researchers find that the vaccine was tolerable and immune-producing 28 days after vaccination.Researchers find that the vaccine was tolerable and immune-producing 28 days after vaccination.

China's COVID-19 vaccine shows promise; groups warn about childhood vaccine disruptions | CIDRAP

The patients’ immune responses linked to the disease's severity.The patients’ immune responses linked to the disease's severity.

Survey of patients correlates COVID-19 severity with immune system changes | Ars Technica

The patients’ immune responses linked to the disease's severity.The patients’ immune responses linked to the disease's severity.

Survey of patients correlates COVID-19 severity with immune system changes | Ars Technica

A new review discusses the findings from over 40 studies on coronavirus immunity and what they could mean for the Covid-19 pandemic.A new review discusses the findings from over 40 studies on coronavirus immunity and what they could mean for the Covid-19 pandemic.

New review discusses findings on coronavirus immunity

First human trial for adenovirus type-5 vectored vaccine adequate to move into phase II, researchers sayFirst human trial for adenovirus type-5 vectored vaccine adequate to move into phase II, researchers say

COVID-19 Vax Safe, Produced Responses in Healthy Chinese Adults | MedPage Today

An early stage trial of a Chinese coronavirus vaccine published in The Lancet medical journal found that it could be a safe and effective mAn early stage trial of a Chinese coronavirus vaccine published in The Lancet medical journal found that it could be a safe and effective m

Scientists say new Chinese vaccine may be safe after early stage trials | TheHill

An early stage trial of a Chinese coronavirus vaccine published in The Lancet medical journal found that it could be a safe and effective mAn early stage trial of a Chinese coronavirus vaccine published in The Lancet medical journal found that it could be a safe and effective m

Scientists say new Chinese vaccine may be safe after early stage trials | TheHill

Chinese researchers have reported promising results from an animal trial of a potential vaccine for COVID-19. Chinese researchers have reported promising results from an animal trial of a potential vaccine for COVID-19.

COVID-19 Vaccine Trial Produced ‘Immediate’ Immune Response in Mice - Chinese Researchers - Sputnik International

Researchers found COVID-19 infection produces a strong T cell response. Here’s why they say that is good newsResearchers found COVID-19 infection produces a strong T cell response. Here’s why they say that is good news

Early Coronavirus Immunity Data Fuel Promise for a Vaccine - Scientific American

A pair of studies on coronavirus may help clue scientists in to developing a vaccine. The studies involved injecting the virus into monkeys, and of those that recovered, they seem to have developed an immunity to the disease.The studies were published on Wednesday, according to Reuters, which [...]A pair of studies on coronavirus may help clue scientists in to developing a vaccine. The studies [...]

Monkeys Infected With Coronavirus Develop Immunity, 2 Studies Say

Monkeys Infected With Coronavirus Develop Immunity, 2 Studies Say

A trail blazing study of 108 adults finds the vaccine produced neutralising antibodies and T-cell response against SARS-CoV-2A trail blazing study of 108 adults finds the vaccine produced neutralising antibodies and T-cell response against SARS-CoV-2

First successful human trial of Covid-19 vaccine finds it 'safe for use' - Daily Star

The experimental vaccine is now being tested in a larger, mid-stage trial. Researchers said the early findings in 108 people support further study.The experimental vaccine is now being tested in a larger, mid-stage trial. Researchers said the early findings in 108 people support further study.

CanSino Biologics coronavirus vaccine human results - Business Insider

Blood samples from a group of 108 vaccinated adults showed both neutralizing antibodies and T-cell responses against the novel coronavirus in most of those tested. "However ... the ability to trigger these immune responses does not necessarily indicate that the vaccine will protect humans fromBlood samples from a group of 108 vaccinated adults showed both neutralizing antibodies and T-cell responses against the novel coronavirus in most of those tested. "However ... the ability to trigger these immune responses does not necessarily indicate that the vaccine will protect humans from

CanSino coronavirus vaccine appears safe in first human trial

A Chinese drugmaker published a paper detailing promising data on a Phase 1 trial of its own Covid-19 vaccine candidate.A Chinese drugmaker published a paper detailing promising data on a Phase 1 trial of its own Covid-19 vaccine candidate.

Chinese Covid-19 Vaccine Trial Data Are a Good Sign for J&J and AstraZeneca’s Efforts - Barron's

Two new coronavirus studies prove that COVID-19 immunity can be obtained either via direct exposure to SARS-CoV-2 or via a vaccine. Researchers have used rhesus macaque to show that reinfection isn’t possible for COVID-19 survivors or for subjects who received vaccine candidates.Two new coronavirus studies prove that COVID-19 immunity can be obtained either via direct exposure to SARS-CoV-2 or via a vaccine. Researchers have used rhesus macaque to show that reinfection isn…

This is the best coronavirus news we’ve seen all month – BGR

Chinese team develops COVID-19 vaccine candidate through new approach - CGTN

Data on the vaccine were published in the Lancet, the first time Phase 1 trial data from any Covid-19 vaccine have been published in a journal.Data on the vaccine were published in the Lancet, the first time Phase 1 trial data from any Covid-19 vaccine have been published in a journal.

Early study of Covid-19 vaccine developed in China sees mixed results

Two studies in monkeys have discovered the first scientific evidence that surviving coronavirus may result in immunity from reinfection.  In one of the new studies, researchers infected nine monkeys with Covid-19, the illness caused by the novel coronavirus.   After they recovered, the team exposed the animals to the virus again and they did not get sick. Two studies in monkeys have discovered the first scientific evidence that surviving coronavirus may result in immunity from reinfection.  In one of the new studies, researchers infected nine monkeys

Monkeys infected with coronavirus develop immunity and boost hopes of vaccine in Harvard study | The Independent

BOSTON (WHDH) - As economies continue to reopen worldwide, people are wondering if they will be safe from the virus. New anti-body testing from Beth...

Beth Israel anti-body testing provides new insight and hope in coronavirus fight – Boston News, Weather, Sports | WHDH 7News

As economies continue to reopen worldwide, people are wondering if they will be safe from the virus. New anti-body testing from Beth Israel Deaconess Medical Center could provide crucial informatio…

Beth Israel anti-body testing provides new insight and hope in coronavirus fight – Boston News, Weather, Sports | WHDH 7News

The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

Bloomberg - Are you a robot?

Some recent news items offer clues as to how investors will respond when the FDA approves a SARS-CoV-2 vaccine.Some recent news items offer clues as to how investors will respond when the FDA approves a SARS-CoV-2 vaccine.

How a Coronavirus Vaccine Might Move the Stock Market | The Motley Fool

Vaccines developed by scientists in the United States have been shown to be effective in protecting monkeys against the coronavirus that causes Covid-19.Researchers from the Beth Israel Deaconess Medical Centre (BIDMC) in Boston, Massachusetts carried out two studies using six DNA vaccine candidatesVaccines developed by scientists in the United States have been shown to be effective in protecting monkeys against the coronavirus that causes Covid-19.Researchers from the Beth Israel Deaconess Medical Centre (BIDMC) in Boston, Massachusetts carried out two studies using six DNA vaccine candidates

Coronavirus: US vaccine protects macaques from Covid-19, studies show

Why%20we%20might%20not%20get%20a%20coronavirus%20vaccine%20%7C%20Coronavirus%20outbreak%20%7C%20The%20GuardianPoliticians have become more cautious about immunisation prospects. They are right to be

Why we might not get a coronavirus vaccine | Coronavirus outbreak | The Guardian

A possible vaccine against the strain of coronavirus causing the COVID-19 pandemic has seen early signs of success in China. However, we are "still a long way from a vaccine for all," a Beijing scientist warned.A possible vaccine against the strain of coronavirus causing the COVID-19 pandemic has seen early signs of success in China. However, we are "still a long way from a vaccine for all," a Beijing scientist warned.

Coronavirus vaccine human tests show initial promise | News | DW | 22.05.2020

Monkeys that have survived Covid-19 are immune to getting it again, at least initially and several vaccines appear to have the same effectSurviving Covid-19 or receiving preliminary vaccines gives monkeys protective immunity to SARS-CoV-2. Although we don't yet know how long the protection la

Monkeys Gain Immunity From Covid-19 and Potential Vaccines | IFLScience

Developed by Beijing-based firm, the vaccine shows development of both forms of immunity  Developed by Beijing-based firm, the vaccine shows development of both forms of immunity  

First human trial of COVID-19 vaccine gives positive results

Two new studies demonstrate vaccine protection by showing that SARS-CoV-2 infection induced protective immunity against re-exposure in nonhuman primates.Two new studies demonstrate vaccine protection by showing that SARS-CoV-2 infection induced protective immunity against re-exposure in nonhuman primates.

SARS-CoV-2 Prototype Vaccine Protects Macaques

Two studies involving testing experimental coronavirus vaccines in monkeys have shown promising results suggestive of immunity and protection against COVID-19. The researchers say that further studies need to be conducted to determine if the same results will be seen in human subjects.Two studies involving testing experimental coronavirus vaccines in monkeys have shown promising results suggestive of immunity and protection against COVID-19. The researchers say that further studies need to be conducted to determine if the same results will be seen in human subjects.

Two Harvard-led Coronavirus Vaccine Trials Conducted on Monkeys Demonstrated Protection and Immunity Against the Virus | Science Times

[media type="image" id="767881" layout="medium" position="left" caption="1"][/media] Death toll nears 330,000The novel coronavirus has killed at least 328,220 people since the outbreak first emerged in China last December, according to a tally from official

Coronavirus Pandemic: Key Updates | The Daily Star

In a matter of months, novel coronavirus has turned the whole world upside downIn a matter of months, novel coronavirus has turned the whole world upside down

Why the vaccine for COVID-19 is still several months away

The findings land just before researchers at Dalhousie University test the same vaccine in Halifax in the upcoming weeks.The findings land just before researchers at Dalhousie University test the same vaccine in Halifax in the upcoming weeks.

Coronavirus vaccine trial shows promising results ahead of Canadian tests | Globalnews.ca

The findings land just before researchers at Dalhousie University test the same vaccine in Halifax in the upcoming weeks.

Coronavirus vaccine trial shows promising results ahead of Canadian tests | Globalnews.ca